This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
8 Aug 2011

XOMA Announces 2Q Financial Results

Xoma Ltd. announced their most recent earnings results for the quarter ended in June 2011 with a net loss of $8.1 million, or $0.27 per share.

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, has announced its financial results for the second quarter and six months ended June 30, 2011.

 

XOMA had total revenues of $16.5 million in the second quarter of 2011 compared with $5.9 million in the second quarter of 2010. The increase in revenues in the 2011 period compared with the 2010 period was due primarily to funding from the company's collaborative partner Les Laboratoires Servier for XOMA 052 development and increased funding under the company's contracts with the U.S. government for XOMA 3AB development.

 

XOMA had a net loss of $8.1 million, or $0.27 per share, for the second quarter of 2011, compared with a net loss of $15.6 million, or $0.93 per share,

Related News